ContributorsPublishersAdvertisers

TST001 Under Evaluation in Locally Advanced or Metastatic Solid Tumors

onclive.com
 2022-01-23

Cover picture for the articleThe safety and tolerability of TST001 is under investigation as a potential treatment option for patients with gastric/gastroesophageal junction cancer and other locally advanced or metastatic solid tumors as part of a phase 1 trial. The safety and tolerability of TST001, a high affinity humanized IgG1 monoclonal antibody to...

www.onclive.com

Comments / 0

Comments / 0